GSK/Ivannova study Relvar/Breo once-daily cobination
GlaxoSmithKline and Innoviva have started a phase III study to compare certain triple combination asthma therapy with a double combination…
Pharmaceuticals, Biotechnology and Life Sciences
GlaxoSmithKline and Innoviva have started a phase III study to compare certain triple combination asthma therapy with a double combination…
The U.S. Food and Drug Administration (FDA) has found that the mental-health side effect risk of Pfizer’s and GSK’s quitting…
Bangladesh-based drugmaker Beximco has received approval for its Bristol-Myers Squibb’s (BMS) generic equivalent Glucophage XR tablets, Metformin from the US…
Vertex Pharmaceuticals Incorporated has reached a pricing and reimbursement agreement for Orkambi (lumacaftor/ivacaftor) with the German Federal Association of the…
Gedeon Richter Plc., a Hungarian drugmaker has withdrawn its Marketing Authorization Application (MAA) from the European Medicines Agency (EMA) for…
Adocia and Eli Lilly have completed an insulin pump study under the Adocia-Lilly partnership evaluating BioChaperone Lispro, an ultra-rapid formulation…
Innate Pharma has announced key leadership team and Board changes which will take effect on December 30th, 2016.
Danish pharmaceutical company Veloxis Pharmaceuticals A/S, has increased its capital by 1,500,000 new shares. The company said on Monday that…
MDxHealth has signed a distribution agreement with AceCGT Life Science Limited for their SelectMDx for Prostate Cancer assay in Hong Kong…
The American Diabetes Association (ADA) has included new recommendation about the use of Jardiance tablets for type 2 diabetes patients…